REal world information on cardiovascular drug management patterns in Acute Coronary Syndrome paTients - RE-ACT
Study identifier:NIS-CBG-XXX-2013/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
REal world information on cardiovascular drug management patterns in Acute Coronary Syndrome paTients
Medical condition
Acute Coronary Syndrome
Phase
N/A
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
814
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Feb 2014
Primary Completion Date: 01 Sept 2014
Study Completion Date: 01 Sept 2014
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Sept 2015 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Patients with STEMI and NSTEMI Patients aged 18 years or older, hospitalized and diagnosed with STEMI (ST-segment elevation myocardial infarction) or NSTEMI (non-ST-segment elevation myocardial infarction) within 24 hours of symptom onset. | - |
Contacts
Investigators
Principal Investigator
Elina Trendafilova
National Cardiology Hospital, Sofia
